You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Claims for Patent: 11,850,222


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,850,222
Title:Sotalol compositions and uses of the same
Abstract:The present invention provides oral solutions containing sotalol hydrochloride which advantageously avoid swallowing while providing with improved stability. The present invention also relates to methods of using the oral solutions for treatment of diseases and disorders, such as delay in reoccurrence of atrial fibrillation/atrial flutter and/or ventricular arrhythmias.
Inventor(s):H. Greg Thomas, Jeffrey S. Kiel
Assignee: Arbor Pharmaceuticals LLC
Application Number:US17/036,790
Patent Claims: 1. A method of treating ventricular arrhythmia in a patient in need thereof comprising administering an oral solution comprising sotalol hydrochloride, wherein the oral solution is administered in a dose of about 80 mg sotalol hydrochloride once or twice daily; and wherein (i) the oral solution is administered in a dose of about 80 mg sotalol hydrochloride twice a day in a patient with a creatinine clearance greater than 60 mL/min or (ii) the oral solution is administered in a dose of about 80 mg sotalol hydrochloride once a day in a patient with a creatinine clearance between 40 and 60 mL/min.

2. The method of claim 1, wherein the ventricular arrhythmia is ventricular tachycardia.

3. The method of claim 1, wherein the ventricular arrhythmia is ventricular fibrillation.

4. The method of claim 1, wherein the dose is increased up to 320 mg sotalol hydrochloride once or twice a day.

5. The method of claim 1, wherein the dose is increased in increments of 80 mg sotalol hydrochloride per day for three days.

6. The method of claim 1, further comprising monitoring the QT interval corrected for heart rate (QTc) of the patient during dose escalation.

7. A method of delaying recurrence of atrial fibrillation/atria flutter in a patient in need thereof comprising administering an oral solution comprising sotalol hydrochloride, wherein the oral solution is administered in a dose of about 80 mg sotalol hydrochloride once or twice daily, and wherein (i) the oral solution is administered in a dose of about 80 mg sotalol hydrochloride twice a day in a patient with a creatinine clearance greater than 60 mL/min or (ii) the oral solution is administered in a dose of about 80 mg sotalol hydrochloride once a day in a patient with a creatinine clearance between 40 and 60 mL/min.

8. The method of claim 7, wherein the dose is increased up to 320 mg sotalol hydrochloride once or twice a day.

9. The method of claim 7, wherein the dose is increased in increments of 80 mg sotalol hydrochloride per day for three days.

10. The method of claim 7, further comprising monitoring the QT interval corrected for heart rate (QTc) of the patient during dose escalation.

11. A method of treating ventricular arrhythmia in a patient in need thereof comprising administering an oral solution comprising sotalol hydrochloride, wherein the oral solution is administered in a dose of about 80 mg sotalol hydrochloride once or twice daily, and wherein the method further comprises monitoring the QT interval corrected for heart rate (QTc) of the patient during dose escalation.

12. The method of claim 11, wherein the ventricular arrhythmia is ventricular tachycardia.

13. The method of claim 11, wherein the ventricular arrhythmia is ventricular fibrillation.

14. The method of claim 11, wherein the dose is increased up to 320 mg sotalol hydrochloride once or twice a day.

15. The method of claim 11, wherein the dose is increased in increments of 80 mg sotalol hydrochloride.

16. A method of delaying recurrence of atrial fibrillation/atria flutter in a patient in need thereof comprising administering an oral solution comprising sotalol hydrochloride, wherein the oral solution is administered in a dose of about 80 mg sotalol hydrochloride once or twice daily, and wherein the method further comprises monitoring the QT interval corrected for heart rate (QTc) of the patient during dose escalation.

17. The method of claim 16, wherein the dose is increased in increments of 80 mg sotalol hydrochloride.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.